Precision Medicine

Precision Medicine Group is a leading next-generation life science services company that supports pharmaceutical and biotech innovators throughout the drug development and commercialization lifecycle. Founded in 2012, the company operates through two primary divisions: Precision for Medicine, a specialized biomarker-driven CRO, and Precision AQ (formerly Precision Value & Health), which focuses on market access and commercial strategy. PMG integrates laboratory expertise, clinical trial excellence, and advanced data science to provide critical insights into patient biology and accelerate the delivery of novel therapies. With over 3,500 employees and a global footprint, the company has supported a significant majority of FDA-approved cell and gene therapies. The firm is backed by major private equity investors including Blackstone and TPG.